Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HPGD | P15428 | 1/20 | 0.59 |
| ▸ | HINT1 | P49773 | 5/20 | 0.55 |
| ▸ | NT5E | P21589 | 1/20 | 0.55 |
| ▸ | GSK3A | P49840 | 2/20 | 0.54 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.54 |
| ▸ | MAPK14 | Q16539 | 2/20 | 0.54 |
| ▸ | TGM2 | P21980 | 1/20 | 0.53 |
| ▸ | PNP | P00491 | 2/20 | 0.52 |
| ▸ | PAX8 | Q06710 | 1/20 | 0.52 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.51 |
| ▸ | ADORA2B | P29275 | 2/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Guanosine SCHEMBL936682 | 0.96 | HPGD (0.55) | HPGDHINT1NT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL8995759 | 0.89 | HPGD (0.62) | HPGDHINT1NT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL3055871 | 0.88 | HPGD (0.63) | HPGDHINT1NT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL531207 | 0.87 | HPGD (0.76) | HPGDHINT1NT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL24049608 | 0.87 | HPGD (0.76) | HPGDHINT1NT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL24049417 | 0.87 | HPGD (0.76) | HPGDHINT1NT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL24049467 | 0.87 | HPGD (0.76) | HPGDHINT1NT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL20750695 | 0.87 | HPGD (0.76) | HPGDHINT1NT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL413586 | 0.87 | HPGD (0.76) | HPGDHINT1NT5EGSK3ARPS6KA3 | |
| Guanosine SCHEMBL24049416 | 0.87 | HPGD (0.76) | HPGDHINT1NT5EGSK3ARPS6KA3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100075414-A1 | GROWTH OF FOREIGN CELLS AFTER CONDITIONAL AND SELECTIVE DESTRUCTION OF FETAL HOST CELLS | XIMEREX, INC. (US) | 2010-03-25 | — | — | US | claimed |
| US-7626075-B2 | Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells | XIMEREX, INC. (US) | 2009-12-01 | — | — | US | claimed |
| US-20070134212-A1 | Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells | XIMEREX, INC. (US) | 2007-06-14 | — | — | US | claimed |
| EP-1545215-A2 | GROWTH OF FOREIGN CELLS IN FETAL ANIMALS FACILITATED BY CONDITIONAL AND SELECTIVE DESTRUCTION OF NATIVE HOST CELLS | Ximerex, Inc. (US) | 2005-06-29 | — | — | EP | claimed |
| WO-2004027029-A2 | GROWTH OF FOREIGN CELLS IN FETAL ANIMALS FACILITATED BY CONDITIONAL AND SELECTIVE DESTRUCTION OF NATIVE HOST CELLS | XIMEREX, INC. (US) | 2004-04-01 | — | — | WO | claimed |
| US-20100075414-A1 | GROWTH OF FOREIGN CELLS AFTER CONDITIONAL AND SELECTIVE DESTRUCTION OF FETAL HOST CELLS | XIMEREX, INC. (US) | 2010-03-25 | — | — | US | disclosed |
| US-7626075-B2 | Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells | XIMEREX, INC. (US) | 2009-12-01 | — | — | US | disclosed |
| EP-1855534-A4 | FACILITATED CELLULAR RECONSTITUTION OF ORGANS AND TISSUES | DIAMOND PAUL (US) | 2008-12-17 | — | — | EP | disclosed |
| EP-1855534-A2 | FACILITATED CELLULAR RECONSTITUTION OF ORGANS AND TISSUES | Diamond, Paul (US) | 2007-11-21 | — | — | EP | disclosed |
| US-20070240235-A1 | METHODS FOR SUPPORTING AND PRODUCING HUMAN CELLS AND TISSUES IN NON-HUMAN MAMMAL HOSTS | DIAMOND PAUL | 2007-10-11 | — | — | US | disclosed |
| US-20070134212-A1 | Growth of foreign cells in fetal animals facilitated by conditional and selective destruction of native host cells | XIMEREX, INC. (US) | 2007-06-14 | — | — | US | disclosed |
| WO-2006074012-A2 | FACILITATED CELLULAR RECONSTITUTION OF ORGANS AND TISSUES | DIAMOND PAUL (US) | 2006-07-13 | — | — | WO | disclosed |
| EP-0282512-A1 | MESSENGER RNA STABILIZATION IN ANIMAL CELLS | DAMON BIOTECH, INC. (US) | 1988-09-21 | — | — | EP | disclosed |
| EP-0272315-A1 | RECOMBINANT HUMAN TISSUE PLASMINOGEN ACTIVATOR COMPOSITION | DAMON BIOTECH, INC. (US) | 1988-06-29 | — | — | EP | disclosed |
| WO-1988002029-A1 | MESSENGER RNA STABILIZATION IN ANIMAL CELLS | DAMON BIOTECH, INC. (US) | 1988-03-24 | — | — | WO | disclosed |
| WO-1988000242-A1 | RECOMBINANT HUMAN TISSUE PLASMINOGEN ACTIVATOR COMPOSITION | DAMON BIOTECH, INC. (US) | 1988-01-14 | — | — | WO | disclosed |
| EP-0237157-A2 | Vector and method for achieving high level expression in cells | Abbott Biotech, Inc. (US) | 1987-09-16 | — | — | EP | disclosed |
| EP-0191606-A2 | Vectors and methods for expression of human protein C activity | ELI LILLY AND COMPANY (US) | 1986-08-20 | — | — | EP | disclosed |
| EP-0172194-A1 | CONTROL SYSTEMS FOR RECOMBINANT MANIPULATIONS. | CETUS CORP (US) | 1986-02-26 | — | — | EP | disclosed |
| WO-1985003522-A1 | MONITORING AND CONTROL SYSTEMS FOR RECOMBINANT MANIPULATIONS | CETUS CORPORATION (US) | 1985-08-15 | — | — | WO | disclosed |